A cytokine-activated cascade is proposed to underlie neurodegenerative changes in the human CNS in a variety of diverse situations ranging from those with a well-defined genetic basis (Down's Syndrome) to head injury to aging (Alzheimer's disease). The hypothesis is that associated with this diversity of neuropathological conditions is an array of glial interactions common to all. The overall goal is to evaluate key components of the proposed cytokine cascade in well established models in this laboratory in which numbers and types of glia can be altered in a known fashion. Animal models in which glial populations in the spinal cord are manipulated with little or no physical invasion of the CNS environment will be used. In one model the sciatic nerve will be injured in order to activate both astrocytes and microglia and to induce proliferation of microglia. This combination of glial responses simulates that noted in neurodegenerative diseases in humans. A second model will involve depletion of these glial populations by exposure of the lumbosacral spinal cord to X-rays followed by injury to the sciatic nerve. The glial-depleted state present at the time of the added challenge, sciatic injury, should result in an alteration in the cytokine-activated cascade. Another model will permit comparisons between neural injuries known to result in failed regeneration (sciatic nerve axotomy) vs. successful regeneration (sciatic nerve crush). Glial responses differ morphologically between these two conditions, and aspects of the cascade are anticipated to differ also. The final model will involve a direct alteration of the glial composition of the spinal cord by transplantation of purified, cultured astrocytes or microglia into the glia-depleted environment of the irradiated cord at the time of sciatic nerve injury. Together, these animal models provide a powerful range of control of glial composition in vivo. Transplantation of the individual cell types has the potential of identifying roles of each in the cascade or of interrupting the cascade. Information of this type is fundamental to the design of a strategy(ies) to interfere with or intervene into the propagated cascade.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
7P01AG012411-02
Application #
5204960
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Lamture, Gauri; Crooks, Peter A; Borrelli, Michael J (2018) Actinomycin-D and dimethylamino-parthenolide synergism in treating human pancreatic cancer cells. Drug Dev Res 79:287-294
Kiaei, Mahmoud; Balasubramaniam, Meenakshisundaram; Govind Kumar, Vivek et al. (2018) ALS-causing mutations in profilin-1 alter its conformational dynamics: A computational approach to explain propensity for aggregation. Sci Rep 8:13102
Zafar, Maroof K; Maddukuri, Leena; Ketkar, Amit et al. (2018) A Small-Molecule Inhibitor of Human DNA Polymerase ? Potentiates the Effects of Cisplatin in Tumor Cells. Biochemistry 57:1262-1273
Janganati, Venumadhav; Ponder, Jessica; Balasubramaniam, Meenakshisundaram et al. (2018) MMB triazole analogs are potent NF-?B inhibitors and anti-cancer agents against both hematological and solid tumor cells. Eur J Med Chem 157:562-581
Ayyadevara, Srinivas; Ganne, Akshatha; Hendrix, Rachel D et al. (2018) Functional assessments through novel proteomics approaches: Application to insulin/IGF signaling in neurodegenerative disease'. J Neurosci Methods :
Balasubramaniam, Meenakshisundaram; Ayyadevara, Srinivas; Shmookler Reis, Robert J (2018) Structural insights into pro-aggregation effects of C. elegans CRAM-1 and its human ortholog SERF2. Sci Rep 8:14891
Liu, A K L; Lim, E J; Ahmed, I et al. (2018) Review: Revisiting the human cholinergic nucleus of the diagonal band of Broca. Neuropathol Appl Neurobiol 44:647-662
Balasubramaniam, Meenakshisundaram; Reis, Robert J Shmookler; Ayyadevara, Srinivas et al. (2017) Involvement of tRNAs in replication of human mitochondrial DNA and modifying effects of telomerase. Mech Ageing Dev 166:55-63
Barger, Steven W (2016) Gene regulation and genetics in neurochemistry, past to future. J Neurochem 139 Suppl 2:24-57
Mao, Xianrong; Phanavanh, Bounleut; Hamdan, Hamdan et al. (2016) NF?B-inducing kinase inhibits NF?B activity specifically in neurons of the CNS. J Neurochem 137:154-63

Showing the most recent 10 out of 140 publications